Ventricular receptors activated following myocardial prostaglandin synthesis initiate reflex hypotension, reduction in heart rate, and redistribution of cardiac output in the dog

Circulation Research
T H Hintze, G Kaley


Arachidonic acid (250 micrograms) injected into the left circumflex coronary artery of anesthetized dogs, with carotid arteries tied to reduce baroreflex-induced changes, caused a reduction in heart rate (-15 +/- 1.6 beats/min), mean arterial pressure (-27 +/- 3.4 mm Hg), and left ventricular dP/dt (-939 +/- 138 mm Hg/sec). In contrast, injection of arachidonic acid into the left anterior descending coronary artery caused smaller changes in heart rate (-4.6 +/- 1.6 beats/min), arterial pressure (-14 +/- 2.8 mm Hg), and left ventricular dP/dt (-118 +/- 131 mm Hg/sec). The hypotension following the injection of arachidonic acid results from an increase in perfusion of the kidney and skeletal muscle (as measured by radioactive microspheres), and is entirely reflex, since the changes in renal blood flow, as well as the reduction in heart rate and the hypotension, are eliminated by bilateral vagal section. Increasing the dose of arachidonic acid results in dose-related changes in heart rate, arterial pressure, and left ventricular dP/dt. Prostacyclin and prostaglandin E2, the two principle coronary vasodilator metabolites of arachidonic acid, but not nitroprusside, cause a fall in blood pressure and heart rate, establishing that cor...Continue Reading


May 18, 1978·The New England Journal of Medicine·P Needleman, G Kaley
Jun 29, 1978·Nature·S MoncadaJ R Vane
Oct 1, 1979·Proceedings of the Society for Experimental Biology and Medicine·T H HintzeG Kaley
Mar 1, 1979·European Journal of Pharmacology·K M MullaneJ R Vane
Jan 13, 1977·The New England Journal of Medicine·E Braunwald
Mar 1, 1977·Circulation Research·T H Hintze, G Kaley
Jul 1, 1977·Progress in Cardiovascular Diseases·M A HeymannA M Rudolph
Jan 1, 1975·The American Journal of Cardiology·R J FrinkH M Lowe
Jan 1, 1976·The American Journal of Physiology·G ManciaD E Donald
Jun 12, 1974·Naunyn-Schmiedeberg's Archives of Pharmacology·F R NetoA Antonio
Dec 1, 1974·The Journal of Clinical Investigation·D L EckbergF M Abboud
Aug 1, 1974·The American Journal of Physiology·W C Randall, J A Armour
Nov 1, 1971·The American Journal of Physiology·R J Frink, T N James
Jul 1, 1984·Acta Physiologica Scandinavica·O M SejerstedF Kiil
Sep 1, 1981·Cardiovascular Research·T H HintzeG Kaley
Apr 1, 1954·Physiological Reviews·G S DAWES, J H COMROE


Mar 1, 1990·Journal of the American College of Cardiology·M L KnudtsonH J Duff
Mar 30, 1999·European Journal of Pharmacology·B KisM A Deli
Sep 1, 1992·Clinical and Experimental Pharmacology & Physiology·A J GormanS G Iams
Jun 19, 2001·American Journal of Physiology. Heart and Circulatory Physiology·S Y SunH D Schultz
Jan 15, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Michael J WackerJames A Orr
Jan 1, 1986·Basic Research in Cardiology·V B Fiedler, M Mardin

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Separation Anxiety

Separation anxiety is a type of anxiety disorder that involves excessive distress and anxiety with separation. This may include separation from places or people to which they have a strong emotional connection with. It often affects children more than adults. Here is the latest research on separation anxiety.

KIF1A Associated Neurological Disorder

KIF1A associated neurological disorder (KAND) is a rare neurodegenerative condition caused by mutations in the KIF1A gene. KAND may present with a wide range and severity of symptoms including stiff or weak leg muscles, low muscle tone, a lack of muscle coordination and balance, and intellectual disability. Find the latest research on KAND here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.